Improving Outcomes of Respiratory Patients With Exertional Hypoxemia
Launched by CHANGI GENERAL HOSPITAL · Feb 21, 2023
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called "Improving Outcomes of Respiratory Patients With Exertional Hypoxemia," is looking to see if a new type of pulmonary rehabilitation (a program to help people with lung diseases improve their breathing and physical activity) can work well for patients who have trouble getting enough oxygen during physical activity. The trial is currently recruiting participants aged 21 and older who have experienced breathing difficulties due to conditions like COPD (a lung disease), Covid-19 pneumonia, or other lung issues. To join, patients need to show that they have low oxygen levels during a simple physical test and must be cleared by their doctor and physiotherapist to participate in exercise therapy.
If you or someone you know is eligible and decides to join the trial, you can expect to take part in a structured exercise program designed to improve your breathing and overall health. It's important to note that those with severe uncontrolled medical conditions or who are already in another similar study cannot participate. This trial is a pilot study, meaning it’s an early step to see if the new approach is practical and beneficial for patients, which could lead to better treatments in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 21 years and above
- • Presence of exertional hypoxemia during 1-minute sit-to-stand test
- • diagnosis of acute COPD exacerbation or Covid-19 pneumonia or exacerbation of bronchiectasis or exacerbation of interstitial lung disease
- • physically fit to participate in exercise therapy as determined by both the patient's physician and physiotherapist
- Exclusion Criteria:
- • uncontrolled severe medical conditions
- • currently enrolled in a pulmonary rehabilitation trial
- • unsuitable for randomization as determined by the patient's physician
About Changi General Hospital
Changi General Hospital (CGH) is a leading tertiary healthcare institution in Singapore, renowned for its commitment to providing high-quality patient care and advancing medical research. As a sponsor of clinical trials, CGH leverages its state-of-the-art facilities and multidisciplinary expertise to facilitate innovative research that aims to enhance treatment options and improve patient outcomes. The hospital is dedicated to upholding rigorous ethical standards and regulatory compliance while fostering collaboration with healthcare professionals and researchers to drive advancements in medical science. Through its clinical trials, CGH seeks to contribute to the global body of knowledge and translate research findings into practical applications for better healthcare delivery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Singapore, , Singapore
Patients applied
Trial Officials
Yingjuan Mok
Principal Investigator
Changi General Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials